Wenjia Guo

4PUBLICATIONS
3CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 27, 2026
Dihydroartemisinin Suppresses Hepatocellular Carcinoma Progression by Acting on KIF11 with PI3K/Akt Modulation.

|Feb 03, 2026
ADAM15 Is a Potential Biomarker for Pan-Cancer Prognosis and Immunotherapy: Validation in HCC and COAD.

Wenjia Guo, Yu'e Liu, Wencong Ma

|Jan 28, 2026
Dihydroartemisinin Promotes N1 Polarization of Tumor-Associated Neutrophils and Enhances Their Anti-Tumor Activity via Hub Gene Modulation.

Wenjia Guo, Yu'e Liu, Wencong Ma

|Jun 26, 2025
Harnessing Antioxidants in Cancer Therapy: Opportunities, Challenges, and Future Directions.

Yu'e Liu, Guangzhen Wu, Linjing Feng

Pageof 1

Frequent Collaborators

3 joint publications

Yu'e Liu

1 joint publications

Kaijun Zhao

1 joint publications

Bingdi Chen